Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for HBS INTERNATIONAL CORP�
100.18
-0.04 (-0.04%)
Real-time:   12:42PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 99.55 - 100.37
52 week 82.12 - 100.75
Open 100.24
Vol / Avg. 2.77M/9.20M
Mkt cap 283.40B
P/E 19.15
Div/yield 0.66/2.64
EPS 5.23
Shares 2.83B
Beta 0.52
Inst. own 67%
Jul 14, 2014
Q2 2014 Johnson & Johnson Earnings Release (Estimated) Add to calendar
May 22, 2014
Johnson & Johnson Medical Devices & Diagnostics Business Review - 9:30AM EDT - Add to calendar
May 6, 2014
Johnson & Johnson at Mizuho Securities USA Healthcare Corporate Access Day Add to calendar
Apr 24, 2014
Johnson & Johnson Annual Meeting of Shareholders
Apr 15, 2014
Q1 2014 Johnson & Johnson Earnings Release
Apr 15, 2014
Q1 2014 Johnson & Johnson Earnings Conference Call
Mar 4, 2014
Johnson & Johnson at Cowen Health Care Conference
Feb 24, 2014
Johnson & Johnson at Citi Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 26.09% 19.40%
Operating margin 29.94% 21.69%
EBITD margin - 33.29%
Return on average assets - 10.89%
Return on average equity - 19.92%
Employees 128,100 -
CDP Score - 98 A-

Address

ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 8933
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all countries throughout the world. In March 2013, Johnson & Johnson's Cordis Corporation announced the acquisition of Flexible Stenting Solutions, Inc. In June 2013, Johnson & Johnson announced the opening of the Johnson & Johnson Innovation center in Boston. In August 2013, Johnson & Johnson announced it has completed its acquisition of Aragon Pharmaceuticals, Inc., a pharmaceutical discovery and development company focused on drugs to treat hormonally driven cancers.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Vice President - Finance
Age: 55
Bio & Compensation  - Reuters
Sandra E. Peterson Group Worldwide Chairman
Age: 54
Bio & Compensation  - Reuters
Paulus Stoffels Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group
Age: 51
Bio & Compensation  - Reuters
Michael H. Ullmann Vice President, General Counsel
Age: 54
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Vice President - Global Human Resources
Age: 50
Bio & Compensation  - Reuters
Ernesto Quinteros Chief Design Officer
Age: 51
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 60
Bio & Compensation  - Reuters
Mark B. McClellan M.D., Ph.D. Director
Bio & Compensation  - Reuters
Mary Sue Coleman Ph.D. Independent Director
Age: 69
Bio & Compensation  - Reuters